MDisrupt Webinars

webinar 08 - investing in womens health

Why you’ve got major FOMO about investing in women’s health.

Date: Friday, November 12th, 2021
Time: 12:00 PM – 1:00 PM PST

Women’s health went big in 2021 – got funded, made headlines, became badass! What caused the shift and why? We’ve brought together the trailblazers, the advocates, and the never-give-up-ers to explain women’s health and why investment and innovation in this market segment is just getting started. Buckle up!

In this webinar, we’ll cover:

  • The opportunity in women’s health and why is it one of the most promising areas of investment?
  • The areas of unmet need and hot spots of innovation
  • What the top women’s health companies are doing right
  • The key components to pitching a women’s health start-up


Christina Farr (Moderator)

Health-tech investor at OMERS Ventures

Deena Shakir

Partner at Lux Capital

Amy Divaraniya, PhD

Founder and CEO of Oova

Neel Shah, MD

Chief Medical Officer, Maven Clinic

webinar 07 - women’s health start-ups

Women’s health start-ups are on fire – finally! What took so long?

Date: Thursday, October 28, 2021
Time: 11:00AM – 12:00PM PST

Women’s health is not niche and it’s not some fad. And it’s not just about fertility and pregnancy. Let’s dispel the myths. It’s about the continuum of lifetime health and wellness needs. And it’s on fire! From Rock Health to mainstream media to Maven reaching unicorn status to the funding of multi-segmented start-ups, women’s health is headline news. In this webinar, MDisrupt hosts the founders of a few of those blazing, fearless start-ups.

In this webinar, we’ll cover:

  • What’s behind the sudden meteoric rise of women’s health when the category has been around for so long?
  • Will consumers have to be the early adopters before enterprise jumps in to help scale solutions? 
  • What is the state of innovation in women’s health and what are the unmet needs?
  • How do you fundraise for and start a women’s health company?


Jennifer Lescallett


Ann Garnier

Founder and CEO, Lisa Health

Kaitlin Christine

Founder and CEO, Gabbi

Marina Pavlovic Rivas

Founder and CEO, Eli Health

Paxton Maeder-York

Founder and CEO, Alife health

webinar 06 - Building digital health products that scale

Building digital health products that scale—why chief medical and scientific officers are the key to widespread adoption

Date: Tuesday, August 24, 2021
Time: 11:00AM – 12:00PM PST

Chief Medical Officers and Chief Scientific Officers are critical first hires for a digital health company. From accelerating your product’s path to market to ensuring your claims are bound by science and balancing consumer needs with medical integrity, CMOs and CSOs can be a founding team’s lifeboat.

In this webinar, we’ll cover:

  • A day in the life of a CMO or CSO in a digital health company
  • How CMOs and CSOs with varying backgrounds can play important roles in your business
  • The clash between the commercial mindset and medical responsibility
  • What happens when you don’t have a CMO or CSO from the start


Chet Robson DO, MHCDS, FAAFP (Moderator)

Chief Clinical Officer, Walgreens

Federico Monzon, MD

Strategy Consultant, Medical Genomics

Madhuri Hegde, PhD, DABMG, FACMG

SVP and Chief Scientific Officer, Global Lab Services at PerkinElmer, Inc.

Bernard Esquivel, MD, PhD

Precision Medicine Advocate & Executive Leader


The roles physicians can play in digital health

Date: June 15, 2021
Time: 11:00AM – 12:00PM PST

Beyond the clinic, physicians can play key roles in digital health companies, from helping them build better products faster to being a founder and even an investor. As a clinician, you can have a voice in how digital health products are designed, marketed, and distributed to your peers.

In this webinar, we will cover:

  • Roles physicians can play in digital health companies
  • How to translate a physician’s clinical experience into industry settings
  • Where physicians can have a voice early on within companies
  • How to represent the voice of the clinician in product design and evidence generation


Sandeep Pulim, MD (Moderator)

Chief Medical Officer at Bluestream Health

Danish Nagda, MD, MBA

Founder & CEO at Rezilient Health

Namrata Rastogi, MD

Primary Care Physician, Healthtech Investor & Advisor

Matt Sakumoto, MD

Virtual Primary Care Physician at PlushCare


How will value-based care drive digital health companies to show outcomes and improve evidence generation?

Date: April 13, 2021
Time: 11:00AM – 12:00PM PST

By 2026, health systems will need to show a shift from a fee-for-service model to a value-based care model. This will require health systems, payers, and digital health companies to work together to determine what evidence is needed to demonstrate outcomes. Where do health systems and payers even start in tackling this challenge? It’s all in the numbers . . .

In this webinar, we will cover:

  • What does value-based care mean and what challenges does it pose to our current healthcare ecosystem?
  • What evidence will digital health companies need to generate to convince payers, providers, and health systems in a value-based care setting?
  • What types of outcomes do health systems and payers care about measuring?
  • What types of studies should digital health companies be conducting?
  • What do digital health companies need to do differently to increase their chances of adoption in value-based care settings?


Corinne Stroum, MS (Moderator)

Vice President for Utilization and Cost Solutions, KenSci Extension Lecturer, University of Washington, Methods & Applications of Healthcare Analytics

James Grana, PhD

Chief of Contracting and Network Development Divisions at Rush Health

Eric J. Daza, DrPH, MPS

Lead Biostatistician (Data Science) at Evidation Health

Danish Nagda, MD, MBA

Founder & CEO at Rezilient Health

mdisrupt-webinar-digital health regulation

How will regulation of digital health products be impacted with the new administration?

Date: March 9, 2021
Time: 11:00AM – 12:00PM PST

With the transition to the Biden-Harris Administration, appointing new leadership within the healthcare focused agencies, and the swearing in of the new Congress, the precision medicine industry can expect new attention to critical policy issues including regulation of diagnostic testing, digital health platforms, and at home testing. Is your regulatory team prepared for these changes?

In this webinar, we will cover:

  • What are the priorities of the incoming administration and new Congress?
  • How will these priorities shift the way the FDA is thinking about regulating laboratory developed tests and digital health software?
  • How should regulatory teams in digital health companies start to prepare for these shifts?
  • How will your legal team be thinking about recently implemented regulations during and after the transition?


Jennifer Leib Sc.M., C.G.C. (Moderator)

Founder at Innovation Policy Solutions

Marissa Cruz M.D.

Executive Vice President for Clinical and Regulatory Affairs at Everlywell

Kevin Coker M.S., M.P.H., J.D.

Co-Founder and CEO of Proxima Clinical Research

Delphine O’Rourke J.D.

Partner at Goodwin

A Healthy Disruption 02

Reimagining Population Health Management

Can Genomics Evolve our Sick Care System into a True Healthcare System

Date: December 15, 2020
Time: 11:30 am – 12:30 pm PST

Imagine if our healthcare system could actually prevent us from becoming patients in the first place.

In today’s healthcare, we use only 10% of the data that predicts health outcomes. Genetic information has the potential to radically improve our predictive power and to help risk-stratify the patients at highest and lowest risk of common chronic diseases such as diabetes, cardiovascular disease, and hypertension.

This webinar will explore how using genetics as a routine part of our healthcare can help us improve population health management—by identifying the highest-risk patients and proactively delivering personalized, preventive interventions to the right patients at the right time.

Key themes

  • The channels, tools, and delivery methods that could be used for population health management;
  • How genomics can be paid for when applied as a population health management tool in the transition to value-based care; and
  • How digital health companies should think about building solutions for population health management.


Lisa Alderson (Moderator)

CEO and Co-Founder of Genome Medical

Tony Slonim, MD, DrPH, FACHE

President and CEO, Renown Health

Chet Robson, DO, MHCDS, FAAFP

Chief Clinical Officer, Walgreens

Professor Sir Peter Donnelly, FRS FMedSci

Founder and CEO, Genomics plc

Marcia Guida, MS-CH, MBA, MS-HP,CPC

Senior Director, Value Based Contracting and Medicare Network Operations, Aetna CVS Health

A Healthy Disruption

Social Determinants of Health in the Virtual Care Setting

Date: November 17, 2020
Time: 11:00 am – 12:00 pm PST

In the time of COVID-19, digital health and telehealth capacities are ramping up. These technologies often point to solutions for specific chronic conditions. In this webinar, learn from experts about:

  • How chronic conditions are often underpinned by behavioral complexities such as smoking, diet, alcohol use, physical activity, etc.
  • How digital and healthtech companies can integrate behavioral, social, and clinical care data into product design to create context-aware, intelligent solutions


Kate Wolin, ScD, FACSM, FSBM (Moderator)

Entrepreneurial Executive and Behavioral Epidemiologist

Gina Merchant, Ph.D.

Behavioral Scientist

Aditi U. Joshi MD, MSc, FACEP

Medical Director of JeffConnect

Gary Bennett, Ph.D.

Bishop-MacDermott Family Professor of Psychology & Neuroscience, Global Health and Medicine and Vice Provost for Undergraduate Education at Duke University

Share This